Global Health Ltd (GLOH)

Currency in INR
1,427.10
+29.60(+2.12%)
Closed·
MEDANTA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1,390.801,439.30
52 wk Range
956.001,544.00
Key Statistics
Bid/Ask
1,426.00 / 1,427.10
Prev. Close
1,397.5
Open
1,396
Day's Range
1,390.8-1,439.3
52 wk Range
956-1,544
Volume
232.83K
Average Volume (3m)
277.88K
1-Year Change
14.0038%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MEDANTA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
1,652.16
Upside
+15.77%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Global Health Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

18 Buy
1 Hold
0 Sell
Ratings:
19 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 1,652.16
(+15.77% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
JPMorgan
Buy1,700.00+19.12%1,650.00MaintainNov 05, 2026
Kotak
Buy1,565.00+9.66%1,390.00MaintainNov 05, 2026
ICICI Securities
Buy1,725.00+20.87%1,650.00MaintainNov 05, 2026
Kotak
Buy1,390.00-2.60%1,510.00MaintainOct 29, 2026
Kotak
Buy1,510.00+5.81%1,540.00MaintainOct 01, 2026

Global Health Ltd Earnings Call Summary for Q2/2027

  • Medanta posted Q2 revenue of INR 14.69B (up 34% YoY) and operating EBITDA of INR 3.70B (up 60% YoY); margin expanded to 25.2% from 21%.
  • Noida hospital reached EBITDA breakeven within one year of opening, validating expansion strategy; stock rose 5.5% despite missing EPS estimates.
  • Company plans to add 3,450 beds over coming years, targeting 7,600+ total capacity with capex exceeding INR 6,000 crore over 4-5 years.
  • Cluster 2 (Lucknow, Patna, Noida) outpaced with 63% revenue growth and 110% EBITDA growth; network occupancy improved to 67% from 64%.
  • Management highlighted 12-18 month lag between investments and results; acquired 2.61-acre Ghaziabad site for planned 500-bed hospital.
Last Updated: 2026-11-04, 04:40 a/m
Read Full Transcript

Earnings

Latest Release
Nov 03, 2026
EPS / Forecast
8.20 / 6.85
Revenue / Forecast
14.69B / 13.4B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 23.01
Dividend Yield
0.04%
Industry Median 0.32%
Annualized payout
0.50
Paid annually
5-Years Growth
-
Growth Streak

MEDANTA Income Statement

Compare MEDANTA to Peers and Sector

Metrics to compare
MEDANTA
Peers
Sector
Relationship
P/E Ratio
62.0x55.8x−0.2x
PEG Ratio
6.241.590.00
Price/Book
8.9x6.4x2.6x
Price / LTM Sales
7.6x4.2x2.8x
Upside (Analyst Target)
15.8%22.3%60.9%
Fair Value Upside
Unlock−6.1%9.5%Unlock

Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emergency, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and diabetes, rheumatology and immunology, radiology and imaging, ophthalmology, critical care, dermatology, dentistry, lab and pathology, and dietetics and nutrition, as well as plastic, aesthetic, and reconstructive surgery. It also provides second opinions, lab tests and diagnostics, homecare and elder care services, telemedicine and air ambulance services, and e-ICU services, and health plans checkup services. In addition, the company is involved in trading pharmacy and other medical consumables; and medical and healthcare education activities. The company operates a network of hospitals under the Medanta brand. Global Health Limited was incorporated in 2004 and is based in Gurugram, India.

Employees
12600
Market
India

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
82.49M30.68%114.46B
Other Institutional Investors
45.55M16.94%63.20B
Public Companies & Retail Investors
140.84M52.38%195.43B
Total
268.87M100.00%373.09B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Temasek Holdings (Private) Limited16.70%44,900,99062,304,614
Jaipuria Group6.58%17,705,18224,567,711

People Also Watch

FAQ

What Is the Global Health (MEDANTA) Stock Price Today?

The Global Health stock price today is 1,427.10 INR.

What Stock Exchange Does Global Health Trade On?

Global Health is listed and trades on the India National Stock Exchange.

What Is the Stock Symbol for Global Health?

The stock symbol for Global Health is "MEDANTA."

Does Global Health Pay Dividends? What’s The Current Dividend Yield?

The Global Health dividend yield is 0.0%%.

What Is the Global Health Market Cap?

As of today, Global Health market cap is 383.71B INR.

What Is Global Health's Earnings Per Share (TTM)?

The Global Health EPS (TTM) is 23.01.

When Is the Next Global Health Earnings Date?

Global Health will release its next earnings report on Feb 10, 2027.

From a Technical Analysis Perspective, Is MEDANTA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Global Health Stock Split?

Global Health has split 0 times.

How Many Employees Does Global Health Have?

Global Health has 12600 employees.

What is the current trading status of Global Health (MEDANTA)?

As of Nov 10, 2026, Global Health (MEDANTA) is trading at a price of 1,427.10 INR, with a previous close of 1,397.50 INR. The stock has fluctuated within a day range of 1,390.80 INR to 1,439.30 INR, while its 52-week range spans from 956.00 INR to 1,544.00 INR.

What Is Global Health (MEDANTA) Price Target According to Analysts?

The average 12-month price target for Global Health is 1,652.16 INR, with a high estimate of 1830 INR and a low estimate of 1510 INR. 18 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +15.77% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.